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Abstract
Background: The Neurological Disorders in Central Spain, second survey (NEDICES-2) is a population-based, closed-cohort
study that will include over 8000 subjects aged ≥55 years. It will also include a biobank.
Objective: The objective of this study was to evaluate all major aspects of the NEDICES-2 (methods, database, screening
instruments, and questionnaires, as well as interexpert rating of the neurological diagnoses) in each one of the planned areas (all
of them in central Spain) and to test the possibility of obtaining biological samples from each participant.
Methods: A selection of patients and participants of the planned NEDICES-2 underwent face-to-face interviews including a
comprehensive questionnaire on demographics, current medications, medical conditions, and lifestyle habits. Biological samples
(blood, saliva, urine, and hair) were also obtained. Furthermore, every participant was examined by a neurologist.
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Results: In this pilot study, 567 study participants were enrolled (196 from hospitals and 371 from primary care physician lists).
Of these 567, 310 completed all study procedures (questionnaires and the neurological evaluation). The study was time-consuming
for several primary care physicians. Hence, a few primary care physicians from some areas refused to participate, which led to
a reconfiguration of study areas. In addition, the central biobank needed to be supplemented by the biobanks of local Spanish
National Health System hospitals.
Conclusions: Population-based epidemiological surveys, such as the NEDICES-2, require a pilot study to evaluate the feasibility
of all aspects of a future field study (population selection, methods and instruments to be used, neurological diagnosis agreement,
and data collection).
(JMIR Res Protoc 2019;8(1):e10941)  doi: 10.2196/10941
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Introduction
A pilot study is usually recommended before undertaking
epidemiological research in large populations to study
neurological, psychiatric, or aging-related diseases [1-9].
Surveys investigating neurological diseases are especially
difficult because of the need for an expert diagnosis, as a sizable
proportion of neurological disorders do not have diagnostic
biomarkers [10]. The difficulty increases when epidemiological
surveys require upfront screening to obviate the workload of a
2-phase survey [2]. In this type of neurological research, pilot
studies prior to the field survey become mandatory.
The original Neurological Disorders in Central Spain, first
survey (NEDICES-1) was a closed population-based study,
which followed a cohort over 13 years [2,3,11,12]. The
NEDICES has produced high-quality epidemiological research
on different neurological disorders with >70 peer-reviewed
publications regarding stroke, dementia, parkinsonism, tremor,
and various aspects of aging and mortality. The main limitation
of the NEDICES-1 was the few laboratory data we obtained
from participants; to overcome this limitation, we have
established a new observational survey, the Neurological
Disorders in Central Spain, second survey (NEDICES-2).
The main differences between the NEDICES-1 and NEDICES-2
are the following. First, in the NEDICES-2, we selected
participants through primary care physicians, instead of using
the census as in the NEDICES-1. Currently, the Spanish
National Health System includes virtually all Spanish legal
residents and immigrants. We used computerized data of citizens
assigned to primary care physicians because they perform their
clinical work at Spanish National Health System centers.
Second, this new cohort of participants comprises subjects aged
>54 years. The younger cohort was not included in the original
survey. Third, a tissue bank (biobank) of participants was
created. Fourth, the study areas were not the same as those of
the previous NEDICES survey, although similarly located in
central Spain. Finally, in the NEDICES-2, the computerized
registry of clinical and biological data is centralized in a specific
website.
The main objective of our pilot study was to evaluate all major
aspects of the NEDICES-2 survey (methods, database, screening
instruments, and questionnaires, as well as interexpert rating of
neurological diagnoses) and to test the possibility of obtaining
biological samples from each participant. Another important
objective of this pilot study was to assess the levels of
cooperation among potential participants and identify and
resolve newly arising problems.
Methods
Design
The coordinating center (Research Institute of the University
Hospital “12 Octubre” in Madrid) of the NEDICES-2 designed
all aspects of the survey during 2011-2012, advised by
participating primary care physicians. The methods and
protocols were analogous to the NEDICES-1 survey [2,3,11,12].
Objectives
The NEDICES-2 survey aims to establish a population-based
cohort to investigate major age-related neurological disorders
(essential tremor, Parkinsonism, stroke, mild cognitive
impairment [MCI], and dementia), including the risk factors
and possible biomarkers for such neurological diseases. In
addition, we aim to confirm the general findings of the
NEDICES-1 survey with a new larger cohort, including persons
in late adulthood (age 55-64 years) and to assess the possible
changes in the neurological diseases incidence over time.
Finally, one important aim of this study is to obtain biological
samples (blood, urine, hair, and saliva).
Population and Study Areas (Pilot Study Selection)
The NEDICES-2 survey aims for a baseline cohort population
of approximately 8000 participants; this number was calculated
to adequately detect Parkinson disease, which has the lowest
prevalence and incidence of all neurological disorders studied
in this research [13,14]. We expect a similar attrition as
happened in the NEDICES-1 survey [12]. The areas were
selected to represent rural, semirural, and urban populations.
The composition by age reflects the general Spanish population
aged >54 years (30% in the strata of 55-64 years); this age
composition is like other European cohorts such as the
Rotterdam study [15]. The NEDICES-2 population will be
selected from primary care physicians’ lists to obtain a random
group (400-600 subjects per primary care physician’s list)
representative for age (5-year strata) and sex of subjects aged
55-84 years and of all subjects aged >84 years.
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The coordinating center of the NEDICES-2 set up the pilot field
study and selected the study protocol (questionnaires, scales,
and examinations) with few differences from the NEDICES-1
survey. Furthermore, it developed the telematic utilities for the
survey—specific email, Skype conferences, information website,
and an electronic platform—to collect study data with privacy
requirements. The coordinating center also conducted the pilot
study.
The coordinating center selected 7 areas to survey participants
for the pilot study: Fuentelarreina and Comillas (central Madrid),
Las Margaritas (Getafe, peripheral Madrid), Arganda del Rey
(suburban Madrid, semirural area), Cantalejo (Segovia, rural
area), Burgos county (rural area), Arévalo (Ávila, semirural
area), and Pizarrales (Salamanca, urban area). The participants
were randomly selected (choosing 5 of 20) and stratified by sex
and age (in 5-year age spans) to be evaluated by 7 primary care
physicians. Participants were considered eligible if they had
lived in rural or urban areas for >6 months and did not anticipate
a serious illness that could cause death within the next year. In
addition, for this pilot study, we recruited patients from the
outpatient neurology clinics of both the University Hospital “12
de Octubre” in Madrid and the Burgos University Hospital in
Burgos. These comprised patients diagnosed with the following
neurological disorders: essential tremor, Parkinsonism, stroke,
headache, MCI, and dementia.
Questionnaires and Screening Methods
We administered 3 different types of questionnaires. First, lay
interviewers (mostly students, not in medicine) administered
general questionnaires, including information on the
demographic and social aspects of participants. In addition,
these questionnaires included screening questions (see below)
or brief neuropsychological batteries for detecting or confirming
neurological diseases, such as essential tremor [16-18],
Parkinsonism [13,14,19], stroke [20,21], or MCI or dementia
(37-item version of the Mini-Mental State Examination, clock
drawing test, 11-item version of the Pfeffer Functional Activities
Questionnaire, Word Accentuation test, verbal fluency [animals
and fruits], Trail-Making test, delayed late memory tests, logical
memory, and nomenclature and images) [22-27], which had
been used in the NEDICES-1. Second, primary care physicians
also administered a questionnaire with anthropometric data,
general health status, cardiovascular risk factors, previous
illnesses, clinical comorbidity [28], and current medications.
Furthermore, primary care physicians took standard biochemical
specimens (blood and urine) for registration and for the biobank
(in some cases, hair and saliva were also included). Finally, a
self-reported questionnaire was also completed by each study
participant, providing personal data, professional background,
education and studies, measurements of subjective health
(global, age-comparative, and time-comparative self-rated
health) [29], generic health-related quality of life (European
Quality of Life Scale) [30], Epworth sleepiness scale [31],
physical activity [32], headaches [33], the Beck Depression
Inventory scale [34], social relationships of participants, and
information about their lifestyle (drugs, tobacco, coffee, and
alcohol consumption).
Screening methods for the main neurological disorders were
like those used in the NEDICES-1 survey [2,3,11,12]. A random
sample of approximately 4% of those who had screened negative
in the NEDICES-1 was selected and contacted to assess the
performance of these screening methods [1]. Of 205 subjects
who were contacted, 183 were successfully scheduled for a
neurological examination by a senior neurologist [1]; they all
were examined, and none was found to have essential tremor,
parkinsonism, or stroke; however, 1.1% (2/183) of subjects
were found to have “mild dementia” (95% CI 0.3%-3.9%) [1].
In the NEDICES-1, we included a question for essential tremor
(“have you ever suffered from tremor of the head, hands, or
legs that has lasted longer than several days?”) [17,18]. In
addition, 3 questions were administered to screen for
parkinsonism (questions about the previous diagnosis of
Parkinson disease, tremor, and bradykinesia) [13,14].
Furthermore, we used a validated 9-item questionnaire aimed
at identifying parkinsonism-related symptoms [19]. The
screening instrument for stroke was a Spanish adaptation of the
questionnaire used for screening in the World Health
Organization Multinational Monitoring of Trends and
Determinants in Cardiovascular disease project [35]. The main
screening instruments for MCI or dementia included the Spanish
adaptation of a cognitive test (a 37-item version of the
Mini-Mental State Examination) and an instrumental activity
of daily living scale (11-item version of the Pfeffer Functional
Activities Questionnaire) [22,24]. The sensitivities of both the
37-item version of the Mini-Mental State Examination and the
Pfeffer Functional Activities Questionnaire Scale are >90%
[36].
Ethical Aspects
All participants included in the study gave their written informed
consent after full explanation of the procedure. The study, which
was conducted in accordance with the principles of the 1975
Declaration of Helsinki, was approved by the ethical standards
committee on human experimentation at the University Hospital
“12 de Octubre” (Madrid). Written (signed) informed consent
was obtained from all enrollees. The data collection and biobank
procedures conformed to the Spanish law.
Statistical Analyses
Statistical analyses were performed using SPSS Version 21.0
(IBM Corp). All tests were 2-sided, and the significance was
accepted at the 5% level (alpha=.05). Continuous variables were
compared using Mann-Whitney U test because they were all
nonnormally distributed. Furthermore, chi-square test was used
to analyze categorical variables.
Results
Population
Figure 1 shows the flowchart of the study. The originally
selected population for the pilot study was of 567 participants.
Of them, 34.6% (196/567) were recruited from the outpatient
neurology clinics of both the University Hospital “12 de
Octubre” in Madrid, which provided 168 patients with
neurological diseases and 22 patients without them after a
careful examination, and the Burgos University Hospital in
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Burgos, which provided 6 patients with neurological diseases.
The remaining 65.4% (371/567) participants were selected from
primary care physicians’ lists of the study areas.
Of the subjects recruited from hospitals, 13.3% (26/196) refused
to participate; meanwhile, 86.7% (170/196) were adequately
evaluated (complete data and assessment by a neurologist). Of
the 371 participants selected from primary care physicians’ lists,
8.3% (31/371) were excluded because of change of primary
care physician, change of address, and deaths. Of the remaining
340 who were eligible by the primary care physician assessment,
15.9% (54/340) were excluded because of inadequate evaluation
(institutionalization, unreachable, refusals, and severe diseases).
The remaining 286 fulfilled or were administered the
questionnaires, but 15.4% (44/286) were excluded because of
incomplete data. Finally, 242 participants had complete data;
however, only 57.9% (140/242) participants were eligible for
the final analyses because neurologists could not evaluate 42.1%
(102/242) for several reasons.
Thus, the final sample consisted of 310 participants (61.3%,
190/310, with neurological diseases and 38.7%, 120/310,
without them) who presented all the required data (3
questionnaires, neurological evaluation, and biobank donation;
Table 1). A higher proportion of participants with neurological
diseases were more likely to have depression or depressive
symptoms, cataracts, and score worse on screening tests for
cognitive disorders (37-item version of the Mini-Mental State
Examination and 11-item version of the Pfeffer Functional
Activities Questionnaire). In addition, as expected, they scored
higher in the Parkinson disease screening test and rated their
health as bad or very bad. On the other hand, they were more
likely to be more sedentary. Table 2 shows the final sample of
participant distribution according to neurologists’ diagnosis.
Figure 1. Flow chart of the Neurological Disorders in Central Spain, second survey (NEDICES-2), feasibility pilot study.
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.528.4 (5.2); 8.09.9 (5.6); 8.0Years of education in yearse, mean (SD); median
Main nonneurological disorderse, n (%)
.6438 (20.7)21 (18.4)Diabetes
.9599 (53.5)62 (53.9)Arterial hypertension
.8387 (47.0)56 (48.3)Hypercholesterolemia








.477.2 (1.6); 7.07.0 (1.4); 7.0Sleeping hours, mean (SD); median
.1211.0 (8.9)1 (11.3)Ever smoker (ex-smoker plus current smoker), n (%)
.67103 (54.8)67 (57.3)Ever drinker (ex-drinker plus current drinker), n (%)
.004Physical activity, n (%)
130 (69.1)60 (52.2)Inactive
15 (8.0)6 (5.2)Moderately inactive
20 (10.6)22 (19.1)Moderately active
23 (12.2)27 (23.5)Active
.01Self-rated healthe, n (%)




2 (1.1)1 (0.9)Very poor
Screening tests for cognitive disorderse, mean (SD); median
.0230.7 (5.7); 32.032.2 (4.8); 33.037-item version of the Mini-Mental State Examination
<.0013.2 (6.0); 01.1 (4.0); 011-item version of the Pfeffer Functional Activities Questionnaire
<.0012.8 (2.4); 2.01.0 (1.2); 1.0Parkinson disease screening test, mean (SD); median
.2657 (34.3)29 (27.4)Headache (yes vs no), n (%)
<.0019.7 (6.3); 9.07.1 (5.6); 6.0Beck Depression Inventory scale, mean (SD); median
a98 from hospitals + 22 from primary care physicians’ lists.
b148 from hospitals + 42 from primary care physicians’ lists.
c15 patients had more than one disorder.
JMIR Res Protoc 2019 | vol. 8 | iss. 1 | e10941 | p. 5http://www.researchprotocols.org/2019/1/e10941/
(page number not for citation purposes)
Hernández-Gallego et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
dContinuous variables were compared using the Mann-Whitney U test because they were all nonnormally distributed. Furthermore, the chi-square test
was used to analyze categorical variables.
eData on some participants were missing.
Table 2. Final participant sample (N=310) distribution according to neurologists’ diagnosis.













71.4 (8.1)75.6 (6.5)71.1 (8.4)71.5 (10.2)78.2 (6.8)66.4 (10.5)70.1 (9.6)Age (years), mean (SD)
Gender, n (%)
14 (35.9)12 (52.2)23 (53.5)21 (60.0)11 (39.3)14 (37.8)55 (45.8)Men
25 (64.1)11 (47.8)20 (46.5)14 (40.0)17 (60.7)23 (62.2)65 (54.2)Women
aFifteen participants had more than one disorder.
All selected areas participated in the survey (participant
evaluation and acquisition of biological samples), but the quality
of the information obtained and the clinical workload for
primary care physicians was quite varied, as was the biobank
established in each local area. Primary care physicians of
Arganda del Rey, Las Margaritas (Madrid), and Pizarrales
(Salamanca) had difficulties carrying out the survey because of
high clinical load, and therefore, they refused to participate in
this pilot study; these areas were then replaced by La Alamedilla
(Salamanca, urban area), Calesas, (urban area, Madrid),
Valladolid (urban area), and Cantalejo (rural area, Segovia).
Development of the Pilot Study
Each primary care physician invited selected subjects from
among his or her patient list to join in the survey through a
phone call or a letter. The duration of the interviews with
participants was variable (10-20 minutes). Most participants
signed the informed consent for both clinical participation and
donation to biobanks. The pilot study showed that the central
biobank faced practical difficulties such as shortage of staff,
high costs, and difficulties with sample arrangements in the
University Hospital “12 de Octubre” biobank. The coordinating
center overcame this problem by changing the initial survey
design to use local biobanks as supplements to the central
biobank (except for Madrid, Ávila, and Segovia).
The training of interviewers was satisfactory. Interviewer
questionnaires were digitized and sent to the central website.
Most of the participants’ self-report questionnaires had to be
completed on paper and sent to the coordinating center in this
format. Evaluations by lay interviewers lasted approximately
1 hour and 15 minutes, sometimes up to 3 hours, with a break.
Participants with possible neurological disorders received a
second evaluation performed by a neurologist.
The comprehension of questionnaires was generally adequate,
with some exceptions. The Beck Depression Inventory scale
[34] was difficult to understand for many participants, and the
coordinating center replaced it by the Center for Epidemiologic
Studies Depression Scale [37] for the future field study. The
37-item version of the Mini-Mental State Examination, 11-item
version of the Pfeffer Functional Activities Questionnaire, Word
Accentuation test, verbal fluency, Trail-Making test, delayed
late memory tests, logical memory, and nomenclature and
images [22-25] allowed us to establish the psychometric cuts
for screening for dementia, obtaining sensitivity >95% with
high specificity.
Once the pilot study was completed, it was decided to compile
each subject’s evaluations; these summary sheets were sent to
each primary care physician for them to discuss with each
subject, explain the results obtained, and thank them for their
collaboration.
Interrater Agreement in the Clinical Diagnosis of
Neurologists Who Will Participate in the Field Study
The interrater agreement of cognitive status and tremor disorders
have been published elsewhere [16,38]. Briefly, to assess the
diagnostic agreement of cognitive status (dementia, MCI, and
normal cognition) among neurologists, medical histories of 30
individuals were provided to 27 neurologists (19 consultant
neurologists and 8 neurology residents) [38]. Overall, the
interrater agreement on cognitive status was κ=.76 (95% CI
0.65-0.86), being slightly higher among junior neurologists
(κ=.85, 95% CI 0.73-0.95) than among seniors (κ=.71, 95% CI
0.59-0.83) and residents (κ=.69, 95% CI 0.54-0.81), but without
statistical significance among groups [38]. Dementia severity
showed an overall kappa of .34, .44, and .64 for mild, moderate,
and severe dementia, respectively [38]. Furthermore, clinical
histories and standardized videotaped neurological examinations
of 26 individuals (11 with essential tremor, 7 with Parkinson
disease, 3 diagnostically unclear, 4 normal, and 1 with a tremor
disorder other than essential tremor) were provided to 7
consultant neurologists, 6 neurology residents, and 5 neurology
research fellows. For each of the 26 individuals, neurologists
were asked to assign a diagnosis of “essential tremor” or “no
essential tremor” using the diagnostic criteria proposed by the
Movement Disorders Society [39]. The overall kappa was .61
(substantial agreement), with no differences among consultant
neurologists (κ=.60), neurology residents (κ=.61), and neurology
research fellows (κ=.66) in subgroup analyses [16].
Discussion
A pilot study is the first step in many types of epidemiological
studies such as cross-sectional and longitudinal surveys [2-5,9],
JMIR Res Protoc 2019 | vol. 8 | iss. 1 | e10941 | p. 6http://www.researchprotocols.org/2019/1/e10941/
(page number not for citation purposes)
Hernández-Gallego et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
case-control studies [40], and research investigations [41]. It is
unwise to establish a complex survey without an adequate pilot
study, as was demonstrated by this study.
Participants, in general, were more cooperative than expected.
The main difficulties in the study were unexpected. Specifically,
the study was time consuming for primary care physicians, as
they had to explain it to participants, obtain informed consents,
and complete a summary of their medical history. However,
during the design of the NEDICES-2 survey, the coordinating
center had erroneously considered that the 3 tasks could be
performed in 10 minutes because the lay interviewer had given
written information to participants and because there was a
specific website with an explanation of the study.
Primary care physicians have a heavy workload in Spain. Many
participants required a lengthy explanation of the survey, despite
the good explanation on the website. With the public funds that
we obtained, we could pay external collaborators as
interviewers, but the Spanish National Health System research
policy does not permit payment to primary care physicians,
even if they devote extra time beyond their working hours. All
this caused 3 primary care physicians’ teams to leave this study.
Thus, the coordinating center had to replace these primary care
physicians’ study areas by others, even in other geographical
areas, to overcome this problem.
Another important difficulty was obtaining biological samples
to establish the central biobank at the University Hospital “12
de Octubre” in Madrid. The pilot study showed that the only
possible way to address this problem was to send all biological
samples to each local Spanish National Health System hospital
laboratory (for registration and to establish a local biobank).
Otherwise, the pilot study was successful, partly because the
methods were analogous to the NEDICES-1. Only a few changes
in the screening questionnaires and scales were made after the
pilot survey. Moreover, several tests were established for the
detection of MCI and dementia.
Substantial agreement was demonstrated for the diagnosis of
cognitive status (dementia, MCI, and normal cognition) among
neurologists of different levels of experience [38]. The
agreement rate was lower in the diagnosis of dementia severity.
With respect to tremor disorders, substantial agreement was
also demonstrated for the diagnosis of essential tremor among
neurologists of different levels of expertise [16]. However, the
agreement was lower than that previously reported using the
Washington Heights–Inwood Genetic Study of Essential Tremor
criteria [42].
In conclusion, we feel that it is impossible to undertake a large
and complex neuroepidemiology survey, such as the
NEDICES-2, without a pilot study. It is mandatory first to test
the feasibility of all aspects of a future field study—population
selection, methods, instruments to be used, neurological
diagnosis agreement, and data collection. This pilot study reveals
some serious deficiencies in the selected areas (the ability of
overburdened primary care physicians to collaborate) and the
biological bank configuration that could be solved by the
coordinating center.
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